Show simple item record

dc.contributor.authorWin, Sithu
dc.contributor.authorMiranda-Schaeubinger, Monica
dc.contributor.authorGustavo Durán Saucedo, Ronald
dc.contributor.authorCarballo Jimenez, Paula
dc.contributor.authorFlores, Jorge
dc.contributor.authorMercado-Saavedra, Brandon
dc.contributor.authorCamila Telleria, Lola
dc.contributor.authorRaafs, Anne
dc.contributor.authorVerastegui, Manuela
dc.contributor.authorBern, Caryn
dc.contributor.authorTinajeros, Freddy
dc.contributor.authorHeymans, Stephane
dc.contributor.authorMarcus, Rachel
dc.contributor.authorGilman, Robert H
dc.contributor.authorMukherjee, Monica
dc.contributor.authorChagas Working Group
dc.date.accessioned2022-07-03T01:02:50Z
dc.date.available2022-07-03T01:02:50Z
dc.date.issued2022-08
dc.identifier.issn2352-9067
dc.identifier.otherPMC9136131
dc.identifier.other35647262
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/338720
dc.descriptionFunder: Johns Hopkins Bloomberg School of Public Health
dc.descriptionFunder: National Institute of Allergy and Infectious Diseases
dc.description.abstractBackground: Chagas disease is an endemic protozoan disease with high prevalence in Latin America. Of those infected, 20-30% will develop chronic Chagas cardiomyopathy (CCC) however, prediction using existing clinical criteria remains poor. In this study, we investigated the utility of left ventricular (LV) echocardiographic speckle-tracking global longitudinal strain (GLS) for early detection of CCC. Methods and results: 139 asymptomatic T. cruzi seropositive subjects with normal heart size and normal LV ejection fraction (EF) (stage A or B) were enrolled in this prospective observational study and underwent paired echocardiograms at baseline and 1-year follow-up. Progressors were participants classified as stage C or D at follow-up due to development of symptoms of heart failure, cardiomegaly, or decrease in LVEF. LV GLS was calculated as the average peak systolic strain of 16 LV segments. Measurements were compared between participants who progressed and did not progress by two-sample t-test, and the odds of progression assessed by multivariable logistic regression. Of the 139 participants, 69.8% were female, mean age 55.8 ± 12.5 years, with 12 (8.6%) progressing to Stage C or D at follow-up. Progressors tended to be older, male, with wider QRS duration. LV GLS was -19.0% in progressors vs. -22.4% in non-progressors at baseline, with 71% higher odds of progression per +1% of GLS (adjusted OR 1.71, 95% CI 1.20-2.44, p = 0.003). Conclusion: Baseline LV GLS in participants with CCC stage A or B was predictive of progression within 1-year and may guide timing of clinical follow-up and promote early detection or treatment.
dc.languageeng
dc.publisherElsevier BV
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceessn: 2352-9067
dc.sourcenlmid: 101649525
dc.subjectEchocardiography
dc.subjectChagas Disease
dc.subjectStrain Imaging
dc.subjectChagas Cardiomyopathy
dc.titleEarly identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy.
dc.typeArticle
dc.date.updated2022-07-03T01:02:49Z
prism.publicationNameInt J Cardiol Heart Vasc
prism.volume41
dc.identifier.doi10.17863/CAM.86133
dcterms.dateAccepted2022-05-17
rioxxterms.versionofrecord10.1016/j.ijcha.2022.101060
rioxxterms.versionVoR
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.identifier.eissn2352-9067
pubs.funder-project-idNational Institutes of Health (1R01AI107028-01A1)
cam.issuedOnline2022-05-23


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International